Dr. Zahler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Mailcode: R3
Cleveland, OH 44195Phone+1 216-445-3588Fax+1 216-444-3577
Summary
- I am a pediatric hematologist/oncologist at Cleveland Clinic Children's Hospital. I completed my pediatric residency and pediatric hematology/oncology/stem cell transplantation fellowship training at Maria Fareri Children's Hospital/New York Medical College in Valhalla, NY. My interests include pediatric solid tumors, including Ewing sarcoma, osteosarcoma, rhabdomyosarcoma and non-RMS tumors, neuroblastoma, Wilm's tumor, retinoblastoma, hepatoblastoma, plexiform neurofibromas related to NF1, MPNST and others. I also have an interest in pediatric brain tumors, both low and high-grade, especially medulloblastoma. My research interests include targeted therapies for pediatric solid tumors, as well as evaluating the epigenetic alterations in radiosensitive vs radioresistant rhabdomyosarcoma.
Education & Training
- Westchester Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
- Westchester Medical CenterResidency, Pediatrics, 2010 - 2013
- Philadelphia College of Osteopathic MedicineClass of 2010
Certifications & Licensure
- OH State License 2016 - 2025
- NY State License 2013 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Staff of the Month Cleveland Clinic Children's, 2018-2019, 2021
- Young Investigator Travel Award PBMTC/ASPHO, 2015
- Pediatric ER Award Maria Fareri Children's Hospital, 2013
- Join now to see all
Clinical Trials
- A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma Start of enrollment: 2016 Feb 10
Publications & Presentations
PubMed
- Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.Ajay Gupta, Matthew S Dietz, Richard F Riedel, Aditi Dhir, Scott C Borinstein
Cancer. 2024-12-01 - Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials.Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung Huang, Matt Hall
Pediatric Blood & Cancer. 2024-10-01 - Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.Eashwar Somasundaram, Peter M Anderson, Timothy D Smile, Ahmed Halima, James B Broughman
Scientific Reports. 2023-11-07
Authored Content
- Clinical Ophthalmic Oncology. Chapter 13. Principles and Complications of ChemotherapyJune 2019
- Clinical Ophthalmic Oncology. Chapter 13. Principles and Complications of ChemotherapyJune 2019
Press Mentions
- Greater Cleveland Sports Commission Announces Cleveland Clinic Sports Medicine Courage Award WinnerFebruary 10th, 2021
- Camryn Colahan to Receive Cleveland Clinic Sports Medicine Courage Award During 21st Greater Cleveland Sports AwardsFebruary 10th, 2021
- Vermilion High School Senior Defies Odds, Beats Rare CancerSeptember 24th, 2020
- Join now to see all
Research History
- Principal InvestigatorThe epigenomics of rhabdomyosarcoma: determinants of chemoradioresistance2019 - Present
- FellowEngineering a Dendritic Cell-based Vaccine against Ewing Sarcoma2014 - 2016
Professional Memberships
- Member
- Member
- American Society of Pediatric Hematology & Oncology - ASPHOMember
- Member
- International Society of Pediatric Oncology (SIOP)Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: